Nuclear Medicine/Radiopharmaceuticals Market Key Enhancement, Growth Factors Analysis, Product Overview and Share Forecasted to 2023

New York, November 01, 2018: The nuclear medicine market is expected to exceed more than US$ 4.5 billion by 2021 growing at around 9.0% CAGR for the given forecast period.

Nuclear medicine is special category in medical branch used for diagnosis and treatment of disease in a safe and painless way. Nuclear medicine contain radioactive material which combined called as radiopharmaceutical. The small quantity of radiopharmaceutical is given into human body in the form of injection or swallowing. It goes to specific location of a body where there could be disease or abnormality. It emits radiation called gamma rays and contains gamma camera which helps nuclear medicine physician to see inside the body. It takes pictures of inner body which helps physician to diagnose patients’ disease.

Browser Full Report @: https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

Market Research Engine has published a new report titled as “Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT – Technetium, PET – F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90) & by Application (Oncology, Thyroid, Cardiology) – Global Forecasts to 2021”.

Reasons to buy this Report:

1) Obtain the most up to date information available on all active and planned nuclear medicine industry globally.

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of nuclear medicine industry and unit capacity data.

4) Assess your competitor’s refining portfolio and its evolution.

Report Scope:

The scope of the report includes a detailed study of global and regional markets for various types of nuclear medicine with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Cardinal Health, Inc. (U.S.), GE Healthcare (U.K.), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), Bayer Healthcare (Germany), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt plc (Ireland).. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Nuclear Medicine Market has been segmented as below:

The Global Nuclear Medicine Market is segmented on the lines of Procedural Volume Segment Analysis, Type Analysis, Application Analysis and Regional Analysis. By Procedural Volume Segment Analysis this market is segmented on the basis of Diagnostics, SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Therapeutics, Beta Emitters, Alpha Emitters and Brachytherapy Isotopes. By Type Analysis this market is segmented on the basis of Diagnostics, SPECT Radiopharmaceuticals, Tc-99, Tl-201, Ga-67, I-123, PET Radiopharmaceuticals, F-18, Ru-82, Others, Therapeutics, Beta Emitters, I-131, Sm-153, Rh-186, Y-90, Lu-177, Others, Alpha, Emitters, Ra-223, Brachytherapy Isotopes, I-125, Ir-192, Pa-103, Cs-131 and Others.

By Application Analysis this market is segmented on the basis of Diagnostics, SPECT, Cardiology, Lymphoma, Thyroid, Neurology, Others, PET, Oncology, Cardiology, Neurology, Others, Therapeutics, Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Investments Through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
5.2.1.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.2.1.3 Advances in Radiotracers
5.2.1.4 Increasing Incidence and Prevalence of Cancer and Cardiac Ailments
5.2.2 Restraints
5.2.2.1 Shorter Half-Life of Radiopharmaceuticals
5.2.2.2 High Cost of Nuclear Medicine Equipment
5.2.3 Opportunities
5.2.3.1 High Demand in Emerging Markets
5.2.3.2 Upcoming Radioisotopes
5.2.3.3 Use of Radiopharmaceuticals in Neurological Applications
5.2.4 Challenges
5.2.4.1 Shutdown of Nuclear Reactors

6 Nuclear Medicine Market, By Type

7 Nuclear Medicine Market, By Application

8 Nuclear Medicine Market, By Procedural Volume

9 Global Nuclear Medicine Market, By Region

10 Global Nuclear Medicine Market, By Region

11 Competitive Landscape

12 Company Profiles

12.1 Introduction

12.2 Cardinal Health, Inc.

12.3 Mallinckrodt PLC

12.4 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)

12.5 Lantheus Medical Imaging, Inc.

12.6 Bayer AG

12.7 Bracco Imaging S.P.A

12.8 Eczacibasi-Monrol Nuclear Products

12.9 Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)

12.10 Advanced Accelerator Applications S.A.

12.11 IBA Molecular

 

Other Related Market Research Reports:

Nonalcoholic Steatohepatitis (NASH) Market is Expected to Grow US$ 20.0 Billion By 2025

Neutropenia Treatment Sales Market Overview and Forecast by 2022: KeyPlayers, Region, Types, Applications

Nasal Spray Market is Supposed to Reach US$ 19.5 Billion By 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

The post Nuclear Medicine/Radiopharmaceuticals Market Key Enhancement, Growth Factors Analysis, Product Overview and Share Forecasted to 2023 appeared first on Herald Keeper.

Add Comment